Community Knowledge and Engagement in COVID-19 Vaccination Efforts in Dori, the Capital of Burkina Faso’s Sahel Region, Facing Security and Humanitarian Challenges
Background: The global COVID-19 crisis significantly impacted socioeconomic structures worldwide. To enhance the response, international authorities approved experimental vaccines, and the COVAX initiative facilitated their distribution to various countries. However, successful vaccination campaigns depended on strong public adherence. This study aimed to evaluate the knowledge level of populations in crisis-affected areas and assess their acceptance of the vaccination. Methodology: A descriptive cross-sectional study was carried out from November to December 2022 in the city of Dori. Data were gathered through interviews and a specially designed survey tool. The collected data were processed using Excel and analyzed with SPSS software version 25. Findings: Among the participants, 91.2% (67 out of 73) were informed about COVID-19, and 93.06% perceived the disease as severe. Communication efforts were made, with radio being the most frequently mentioned source of information on the disease and vaccination. Those who remained unvaccinated primarily cited a lack of willingness, distrust, or unawareness of being part of the priority group. Conclusions: The study revealed a commendable level of adherence among respondents, indicating that further efforts are needed to enhance the role of social media as a communication tool to improve outreach and effectiveness.
References
[1]
Ye, Z.-W. and Jin, D.-Y. (2020) Diagnosis, Treatment, Control and Prevention of SARS-CoV-2 and Coronavirus Disease 2019: Back to the Future. Chinese Journal of Biotechnology, 36, 571-592.
[2]
World Health Organisation (2020) Coronavirus Disease 2019 (COVID-19) Situation Report-49. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200309-sitrep-49-covid-19.pdf?sfvrsn=70dabe61_4
[3]
WHO (2020) Déclaration sur la réunion du Comité d’urgence du Règlement sanitaire international (RSI) concernant la flambée de nouveau coronavirus (2019-nCoV). https://www.who.int/fr/news/item/23-01-2020-statement-on-the-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)
[4]
Junot, A., Chabanet, P. and Ridde, V. (2023) Management of the COVID Crisis in Reunion Island (SW Indian Ocean): Representations of COVID-19 and Acceptance of Public Health Measures. Health Psychology and Behavioral Medicine, 11, Article ID: 2252902. https://doi.org/10.1080/21642850.2023.2252902
[5]
Reddy, K.P., Fitzmaurice, K.P., Scott, J.A., Harling, G., Lessells, R.J., Panella, C., et al. (2021) Clinical Outcomes and Cost-Effectiveness of COVID-19 Vaccination in South Africa. Nature Communications, 12, Article No. 6238. https://doi.org/10.1038/s41467-021-26557-5
[6]
Mongbo, Y., Sombie, I., Dao, B., et al. (2021) Maintaining Continuity of Essential Reproductive, Maternal, Neonatal, Child and Adolescent Health Services during the COVID-19 Pandemic in Francophone West Africa. African Journal of Reproductive Health, 25, 76-85.
[7]
Africa CDC (2022) Coronavirus Disease 2019 (COVID-19)。 https://africacdc.org/covid-19/
[8]
Le Monde (2020, December 31) Covid-19 dans le monde: Premier cas détecté en France du variant sud-africain, l’OMS donne son homologation d’urgence au vaccin Pfizer-BioNTech. Le Monde. https://www.lemonde.fr/planete/article/2020/12/31/coronavirus-le-variant-anglais-decou-vert-en-chine-recrudescence-des-deces-aux-etats-unis-une-nouvelle-annee-sous-le-signe-de-la-pandemie_6064897_3244.html
[9]
Centre des operations de reponse aux urgences sanitaires (CORUS): Burkina Faso (2020) Rapport de situation sur l’épidémie à Coronavirus à Wuhan en République populaire de Chine, Janvier 2020. https://www.sig.gov.bf/actualites/details?tx_news_pi1%5Baction%5D=detail&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Bnews%5D=371&cHash=ceac2febe75bddf5edf3973bf7a2b6ad
[10]
Kaboré, N.F., Ouédraogo, S., Mamguem, A.K., Traoré, I.T., Kania, D., Badolo, H., et al. (2023) Incidence Rate and Predictors of COVID-19 in the Two Largest Cities of Burkina Faso—Prospective Cohort Study in 2021 (ANRS-CoV13). BMC Infectious Diseases, 23, Article No. 394. https://doi.org/10.1186/s12879-023-08361-2
[11]
Anyanwu, J.C. and Salami, A.O. (2021) The Impact of COVID‐19 on African Economies: An Introduction. African Development Review, 33, S1-S16. https://doi.org/10.1111/1467-8268.12531
[12]
Ramaroson, H.J.V. and Pourette, D. (2018) Perception des vaccinations de routine et de masse par les mères. Cas du fokontany de Namahora, région Menabe. L’Harmattan, 173-184.
[13]
WHO. Les différents types de vaccins contre la COVID-19. https://www.who.int/fr/news-room/feature-stories/detail/the-race-for-a-covid-19-vaccine-explained#cms
[14]
Kim, J.H., Marks, F. and Clemens, J.D. (2021) Looking beyond COVID-19 Vaccine Phase 3 Trials. Nature Medicine, 27, 205-211. https://doi.org/10.1038/s41591-021-01230-y
[15]
Razai, M.S., Chaudhry, U.A.R., Doerholt, K., Bauld, L. and Majeed, A. (2021) Covid-19 Vaccination Hesitancy. BMJ, 373, n1138. https://doi.org/10.1136/bmj.n1138
[16]
Machingaidze, S. and Wiysonge, C.S. (2021) Understanding COVID-19 Vaccine Hesitancy. Nature Medicine, 27, 1338-1339. https://doi.org/10.1038/s41591-021-01459-7
[17]
Mandal, S., Arinaminpathy, N., Bhargava, B. and Panda, S. (2021) Responsive and Agile Vaccination Strategies against COVID-19 in India. The Lancet Global Health, 9, e1197-e1200. https://doi.org/10.1016/s2214-109x(21)00284-9
[18]
WHO. Le COVAX est l’axe de travail vaccins du dispositif pour accélérer l’accès aux outils de lutte contre la COVID-19. https://www.who.int/fr/initiatives/act-accelerator/covax/covid-19-vaccine-country-readiness-and-delivery
[19]
Nations Unies BF (2021) Le Burkina Faso intensifie la vaccination contre la COVID-19. https://burkinafaso.un.org/fr/166019-le-burkina-faso-intensifie-la-vaccination-contre-la-covid-19
[20]
Ministère de la santé BF. Plan national de déploiement et de vaccination (PNDV) contre la Covid-19 au Burkina Faso.
[21]
OCHA (2020) Aperçu des besoins humanitaires au BURKINA FASO. https://www.bing.com/search?q=bfa_hno_2020_04062020_web.pdf+(un.org)&cvid=6354bc7870a446e99bd9717f9fa7ee7d&aqs=edge..69i57.4722j0j9&FORM=ANAB01&PC=DCTS
[22]
Cluster Sante/Corus BF (2021) Bulletin n°22 du cluster santé. https://reliefweb.int/sites/reliefweb.int/files/resources/bulletin_sectoriel_novembre_2021.pdf
[23]
Cluster Sante/Corus BF (2022) BFA: Bulletin humanitaire N°35 du cluster Santé du Burkina Faso. https://reliefweb.int/report/burkina-faso/bulletin-ndeg35-du-cluster-sante-decembre-2022
[24]
Conasur (2022) Situation actualisée au 30 novembre 2022. Démographie des PDIs Rapport trimestriel, Minsitère de l’action humanitaire.
[25]
Malik, A.A., McFadden, S.M., Elharake, J. and Omer, S.B. (2020) Determinants of COVID-19 Vaccine Acceptance in the Us. EClinicalMedicine, 26, Article ID: 100495. https://doi.org/10.1016/j.eclinm.2020.100495
[26]
Solís Arce, J.S., Warren, S.S., Meriggi, N.F., Scacco, A., McMurry, N., Voors, M., et al. (2021) COVID-19 Vaccine Acceptance and Hesitancy in Low-and Middle-Income Countries. Nature Medicine, 27, 1385-1394. https://doi.org/10.1038/s41591-021-01454-y
[27]
Mose, A., Wasie, A., Shitu, S., Haile, K., Timerga, A., Melis, T., et al. (2022) Determinants of COVID-19 Vaccine Acceptance in Ethiopia: A Systematic Review and Meta-analysis. PLOS ONE, 17, e0269273. https://doi.org/10.1371/journal.pone.0269273
[28]
Wikipédia. Carte des départements de la province du Séno. https://fr.wikipedia.org/wiki/Dori_(d%C3%A9partement)
[29]
Wikipédia. Dori (Burkina Faso). https://fr.wikipedia.org/wiki/Dori_(Burkina_Faso)
[30]
Schwartz D. formule de schwartz échantillonnage. https://www.pdfprof.com/PDF_Image.php?idt=22801&t=17
[31]
Azanaw, J., Endalew, M., Zenbaba, D., Abera, E. and Chattu, V.K. (2023) COVID-19 Vaccine Acceptance and Associated Factors in 13 African Countries: A Systematic Review and Meta-Analysis. Frontiers in Public Health, 10, Article ID: 1001423. https://doi.org/10.3389/fpubh.2022.1001423
[32]
Di Meglio, F., Lhomme, E., Ouedraogo, H.G., Barry, A.M., Doumbia, S., Faye, S.L., et al. (2024) Variations in COVID-19 Vaccine Hesitancy over Time: A Serial Cross-Sectional Study in Five West African Countries. BMJ Open, 14, e083766. https://doi.org/10.1136/bmjopen-2023-083766
[33]
Naidoo, D., Meyer-Weitz, A. and Govender, K. (2023) Factors Influencing the Intention and Uptake of COVID-19 Vaccines on the African Continent: A Scoping Review. Vaccines, 11, Article No. 873. https://doi.org/10.3390/vaccines11040873
[34]
Wang, D., Chukwu, A., Mwanyika-Sando, M., Abubakari, S.W., Assefa, N., Madzorera, I., et al. (2022) COVID-19 Vaccine Hesitancy and Its Determinants among Sub-Saharan African Adolescents. PLOS Global Public Health, 2, e0000611. https://doi.org/10.1371/journal.pgph.0000611
[35]
Deml, M.J. and Githaiga, J.N. (2022) Determinants of COVID-19 Vaccine Hesitancy and Uptake in Sub-Saharan Africa: A Scoping Review. BMJ Open, 12, e066615. https://doi.org/10.1136/bmjopen-2022-066615
[36]
Bogui, J.-J., Atchoua, J., Diallo, S. (2023) Ambivalence des usages des technologies numériques en Côte d’Ivoire. In: Technologies et sociétés africaines au temps des pandémies, British Library Cataloguing-in-Publication Data, 31-48. https://www.istegroup.com/fr/produit/technologies-et-societes-africaines-au-temps-des-pandemies/
[37]
Ouédraogo, H.S., Kabore, Y.L.B., Sawadogo, A.G., Bakouan, M., Sawadogo, N., Mano, M., et al. (2023) Task-Shifting Immunization Activities to Community Health Workers: A Mixed-Method Cross-Sectional Study in Sahel Region, Burkina Faso. Global Health: Science and Practice, 11, e2300044. https://doi.org/10.9745/ghsp-d-23-00044
[38]
Rosenblum, H.G., Hadler, S.C., Moulia, D., Shimabukuro, T.T., Su, J.R., Tepper, N.K., et al. (2021) Use of COVID-19 Vaccines after Reports of Adverse Events among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices—United States, July 2021. MMWR. Morbidity and Mortality Weekly Report, 70, 1094-1099. https://doi.org/10.15585/mmwr.mm7032e4
[39]
Diallo, I., Sawadogo, A., Ouédraogo, G.A., Ouédraogo, S., Diendéré, E.A., Zoungrana, J., et al. (2024) Adverse Events Following Immunization of COVID-19 Vaccines in People Vaccinated from June 2021 to March 2022 in Ouagadougou. Asian Journal of Research in Infectious Diseases, 15, 49-56. https://doi.org/10.9734/ajrid/2024/v15i1325
[40]
Ridde, V., Faye, A., Diallo, A.I., et al. (2021, February 11) Au Sénégal, comment contrer la défiance envers le vaccin anti-Covid-19. https://theconversation.com/au-senegal-comment-contrer-la-defiance-envers-le-vaccin-anti-covid-19-154863
[41]
Davis, C.J., Golding, M. and McKay, R. (2021) Efficacy Information Influences Intention to Take COVID‐19 Vaccine. British Journal of Health Psychology, 27, 300-319. https://doi.org/10.1111/bjhp.12546
[42]
Ridde, V., Ba, M.F., Gaye, I., Diallo, A.I., Bonnet, E. and Faye, A. (2021) Participating in a Vaccine Trial for COVID-19 in Senegal: Trust and Information. Human Vaccines & Immunotherapeutics, 17, 3907-3912. https://doi.org/10.1080/21645515.2021.1951097
[43]
Sevidzem Wirsiy, F., Nkfusai, N.C., Ebot Ako-Arrey, D., Kenfack Dongmo, E., Titu Manjong, F. and Nambile Cumber, S. (2021) Acceptability of COVID-19 Vaccine in Africa. International Journal of Maternal and Child Health and AIDS (IJMA), 10, 134-138. https://doi.org/10.21106/ijma.482
